Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Flavia Salvi, Stefano Luminari, Alessandra Tucci, Stefania Massidda, Anna Marina Liberati, Caterina Stelitano, Manuela Zanni, Alessandro Re, Riccardo Centurioni, Roberto Freilone, Gerardo Musuraca, Luca Nassi, Caterina Patti, Annalisa Arcari, Monica Tani, Alessandro Pulsoni, Vincenzo Pavone, Stefano Volpetti, Annalisa Peli, Andrea EvangelistaMichele Spina, Marco Ladetto, Francesco Merli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)'. Together they form a unique fingerprint.

Medicine & Life Sciences